Literature DB >> 31217357

Clones of infected cells arise early in HIV-infected individuals.

John M Coffin1, David W Wells2, Jennifer M Zerbato3, Joann D Kuruc4, Shuang Guo2, Brian T Luke5, Joseph J Eron4, Michael Bale6, Jonathan Spindler6, Francesco R Simonetti6, Shawn Hill6, Mary F Kearney6, Frank Maldarelli6, Xiaolin Wu2, John W Mellors3, Stephen H Hughes6.   

Abstract

In HIV-infected individuals on long-term antiretroviral therapy (ART), more than 40% of the infected cells are in clones. Although most HIV proviruses present in individuals on long-term ART are defective, including those in clonally expanded cells, there is increasing evidence that clones carrying replication-competent proviruses are common in patients on long-term ART and form part of the HIV reservoir that makes it impossible to cure HIV infection with current ART alone. Given the importance of clonal expansion in HIV persistence, we determined how soon after HIV acquisition infected clones can grow large enough to be detected (clones larger than ca. 1 × 105 cells). We studied 12 individuals sampled in early HIV infection (Fiebig stage III-V/VI) and 5 who were chronically infected. The recently infected individuals were started on ART at or near the time of diagnosis. We isolated more than 6,500 independent integration sites from peripheral blood mononuclear cells before ART was initiated and after 0.5-18 years of suppressive ART. Some infected clones could be detected approximately 4 weeks after HIV infection and some of these clones persisted for years. The results help to explain how the reservoir is established early and persists for years.

Entities:  

Keywords:  AIDS/HIV; Clonal selection; T cells

Year:  2019        PMID: 31217357      PMCID: PMC6629130          DOI: 10.1172/jci.insight.128432

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  48 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection.

Authors:  Rob J De Boer; Dirk Homann; Alan S Perelson
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

3.  Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Authors:  Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard T Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Authors:  D McMahon; J Jones; A Wiegand; S J Gange; M Kearney; S Palmer; S McNulty; J A Metcalf; E Acosta; C Rehm; J M Coffin; J W Mellors; F Maldarelli
Journal:  Clin Infect Dis       Date:  2010-03-15       Impact factor: 9.079

5.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

6.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

7.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

8.  A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load.

Authors:  Mauro S Malnati; Gabriella Scarlatti; Francesca Gatto; Francesca Salvatori; Giulia Cassina; Teresa Rutigliano; Rosy Volpi; Paolo Lusso
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

9.  Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Authors:  J B Dinoso; S Y Kim; A M Wiegand; S E Palmer; S J Gange; L Cranmer; A O'Shea; M Callender; A Spivak; T Brennan; M F Kearney; M A Proschan; J M Mican; C A Rehm; J M Coffin; J W Mellors; R F Siliciano; F Maldarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

10.  The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.

Authors:  Rajesh T Gandhi; Lu Zheng; Ronald J Bosch; Ellen S Chan; David M Margolis; Sarah Read; Beatrice Kallungal; Sarah Palmer; Kathy Medvik; Michael M Lederman; Nadia Alatrakchi; Jeffrey M Jacobson; Ann Wiegand; Mary Kearney; John M Coffin; John W Mellors; Joseph J Eron
Journal:  PLoS Med       Date:  2010-08-10       Impact factor: 11.069

View more
  30 in total

Review 1.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.

Authors:  William R McManus; Michael J Bale; Jonathan Spindler; Ann Wiegand; Andrew Musick; Sean C Patro; Michele D Sobolewski; Victoria K Musick; Elizabeth M Anderson; Joshua C Cyktor; Elias K Halvas; Wei Shao; Daria Wells; Xiaolin Wu; Brandon F Keele; Jeffrey M Milush; Rebecca Hoh; John W Mellors; Stephen H Hughes; Steven G Deeks; John M Coffin; Mary F Kearney
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

3.  Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection.

Authors:  Louise Leyre; Eugène Kroon; Claire Vandergeeten; Carlo Sacdalan; Donn J Colby; Supranee Buranapraditkun; Alexandra Schuetz; Nitiya Chomchey; Mark de Souza; Wendy Bakeman; Rémi Fromentin; Suteeraporn Pinyakorn; Siriwat Akapirat; Rapee Trichavaroj; Suthat Chottanapund; Sopark Manasnayakorn; Rungsun Rerknimitr; Phandee Wattanaboonyoungcharoen; Jerome H Kim; Sodsai Tovanabutra; Timothy W Schacker; Robert O'Connell; Victor G Valcour; Praphan Phanuphak; Merlin L Robb; Nelson Michael; Lydie Trautmann; Nittaya Phanuphak; Jintanat Ananworanich; Nicolas Chomont
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

4.  Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy.

Authors:  Bradley R Jones; Rachel L Miller; Jeffrey B Joy; Zabrina L Brumme; Natalie N Kinloch; Olivia Tsai; Hawley Rigsby; Hanwei Sudderuddin; Aniqa Shahid; Bruce Ganase; Chanson J Brumme; Marianne Harris; Art F Y Poon; Mark A Brockman; Rémi Fromentin; Nicolas Chomont
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

5.  Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.

Authors:  Rogelio Valdez; Gabriella Fenkart; Germán G Gornalusse; Lucia Vojtech; Lamar M Fleming; Urvashi Pandey; Sean M Hughes; Claire N Levy; Erin J Dela Cruz; Fernanda L Calienes; Anna C Kirby; Michael F Fialkow; Gretchen M Lentz; Jessica Wagoner; Lichen Jing; David M Koelle; Stephen J Polyak; David N Fredricks; M Juliana McElrath; Anna Wald; Florian Hladik
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

6.  Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo.

Authors:  Francesco R Simonetti; Hao Zhang; Garshasb P Soroosh; Jiayi Duan; Kyle Rhodehouse; Alison L Hill; Subul A Beg; Kevin McCormick; Hayley E Raymond; Christopher L Nobles; John K Everett; Kyungyoon J Kwon; Jennifer A White; Jun Lai; Joseph B Margolick; Rebecca Hoh; Steven G Deeks; Frederic D Bushman; Janet D Siliciano; Robert F Siliciano
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

7.  The gift of a lifetime: analysis of HIV at autopsy.

Authors:  Frank Maldarelli
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 8.  The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

Authors:  Erin M B Scholz; Angela D M Kashuba
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

9.  CpG Methylation Profiles of HIV-1 Pro-Viral DNA in Individuals on ART.

Authors:  Valerie F Boltz; Cristina Ceriani; Jason W Rausch; Wei Shao; Michael J Bale; Brandon F Keele; Rebecca Hoh; Jeffrey M Milush; Steve G Deeks; Frank Maldarelli; Mary F Kearney; John M Coffin
Journal:  Viruses       Date:  2021-04-29       Impact factor: 5.048

10.  Comparison of methods to quantify inducible HIV-1 outgrowth.

Authors:  P Nathan Enick; Joseph P Brooker; Camille M Tumiotto; Brittany T Staines; Joseph J Eron; Deborah K McMahon; Rajesh T Gandhi; John W Mellors; Michele D Sobolewski
Journal:  J Virus Erad       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.